The Vanguard Group 13D and 13G filings for Alaunos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 10:54 am Sale |
2022-12-30 | 13G | Alaunos Therapeutics, Inc. TCRT |
The Vanguard Group | 60,985 3.810% |
-16,573 (-21.37%) |
Filing |
| 2022-02-10 08:47 am Sale |
2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
The Vanguard Group | 77,558 5.380% |
-28,905 (-27.15%) |
Filing |
| 2021-02-10 12:04 pm Purchase |
2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
The Vanguard Group | 106,463 7.450% |
22,496 (+26.79%) |
Filing |